Moderna, Inc.

Moderna’s mRNA technology quickly enabled Moderna to pivot when the COVID-19 crisis emerged and to manufacture and deliver a safe, effective vaccine against COVID-19.

Lobbying Activity

Meeting with Tilly Metz (Member of the European Parliament, Shadow rapporteur) and Vaccines Europe

10 Sept 2025 · Critical Medicines Act

Meeting with Florika Fink-Hooijer (Director-General Health Emergency Preparedness and Response Authority)

2 Jun 2025 · Pandemic preparedness

Meeting with Stelios Kympouropoulos (Member of the European Parliament) and BioNTech SE

17 Jan 2024 · Kangaroo Lunch debate on Platform Technologies and the pharmaceutical legislation review

Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur) and BioNTech SE

16 Jan 2024 · Pharmaceutical legislation

Meeting with Laura Ballarín Cereza (Member of the European Parliament, Shadow rapporteur for opinion) and BioNTech SE

30 Oct 2023 · Pharmaceutical Package (Directive)

Meeting with Tiemo Wölken (Member of the European Parliament) and

18 Oct 2023 · Pharma Revision - Directive (staff level)

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and

13 Oct 2023 · Directive on Medicinal products for human use

Meeting with István Ujhelyi (Member of the European Parliament)

3 May 2023 · Health

Meeting with Nathalie Colin-Oesterlé (Member of the European Parliament) and Novartis International AG

3 May 2023 · Pharmaceutical review

Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur)

10 Nov 2022 · Lessons learned on impact of COVID-19 pandemic

Meeting with Stella Kyriakides (Commissioner) and

3 Nov 2022 · Videoconference with Moderna CEO on future of mRNA platform; ongoing cooperation on the management of the pandemic

Meeting with Stelios Kympouropoulos (Member of the European Parliament)

11 Oct 2022 · Lessons-learnt from COVID-19

Meeting with Karsten Lucke (Member of the European Parliament)

22 Jul 2022 · Corona Impfstoffe

Meeting with Kathleen Van Brempt (Member of the European Parliament, Committee chair)

31 May 2022 · The current situation of the pandemic and the mRNA technology

Meeting with Ursula von der Leyen (President)

26 Nov 2021 · Meeting with CEO of Moderna

Meeting with Thierry Breton (Commissioner)

10 Apr 2021 · Vaccine production and deliveries

Meeting with Ursula von der Leyen (President) and

31 Jan 2021 · Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements